Anne Gomez‐Brouchet

MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone

Fanny Dujardin, Matthieu Bui Nguyen Binh, Corinne Bouvier et al. · Modern Pathology · 2011 · 233 citations

Bone Disease, Low-grade Osteosarcomas, Bone Imaging +9

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

Sophie Piperno‐Neumann, Marie‐Cécile Le Deley, Françoise Rédiní et al. · The Lancet Oncology · 2016 · 201 citations

Surgical Oncology, Medicine, Metronomic Therapy +7

Intimal Sarcoma Is the Most Frequent Primary Cardiac Sarcoma

Agnès Neuville, Françoise Collin, Patrick Bruneval et al. · The American Journal of Surgical Pathology · 2014 · 172 citations

Cancer Research, Mdm2 Amplification, Cardiac Muscle +13

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Anne Gomez‐Brouchet, Claire Illac, Julia Gilhodes et al. · OncoImmunology · 2017 · 165 citations · Full text

Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism

Florent Morfoisse, Anna Kuchnio, Clément Frainay et al. · Cell Reports · 2014 · 151 citations · Full text